Stem Cells in the Myelodysplastic Syndromes

Stem Cells in the Myelodysplastic Syndromes

The myelodysplastic syndromes (MDS) represent a group of clonal disorders characterized by ineffective hematopoiesis, resulting in peripheral cytopenias and frequent transformation to acute myeloid leukemia (AML). We and others have demonstrated that MDS arises in, and is propagated by malignant ste...

Full description

Bibliographic Details
Main Authors:	Di Zhan, Christopher Y. Park
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Aging
Subjects:	myelodysplastic syndromes hematopoietic stem cells novel therapeutics clonal hematopoiesis acute myeloid leukemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fragi.2021.719010/full

Similar Items

Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia
by: M. Ryan Corces, et al.
Published: (2017-11-01)

Circular RNAs in Hematopoiesis with a Focus on Acute Myeloid Leukemia and Myelodysplastic Syndrome
by: Michaela Dostalova Merkerova, et al.
Published: (2020-08-01)

Genetics of Myelodysplastic Syndromes
by: Caner Saygin, et al.
Published: (2021-07-01)

Salvage Therapy after Allogeneic Hematopoietic Cell Transplantation: Targeted and Low-Intensity Treatment Options in Myelodysplastic Syndrome and Acute Myeloid Leukemia
by: Katie Culos, et al.
Published: (2019-05-01)

The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
by: VN Ovechkina, et al.
Published: (2017-07-01)

Lymphoblastic transformation of myelodysplastic syndrome
by: Carmen Silvia Passos Lima, et al.

Gingival enlargement in myelodysplastic syndrome
by: Navia George, et al.
Published: (2015-01-01)

Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities?
by: Romane Joudinaud, et al.
Published: (2021-08-01)

Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series
by: Grégoire Martin de Frémont, et al.
Published: (2021-10-01)

Alternative Splicing and Regulation of Innate Immune Mediators in Normal and Malignant Hematopoiesis
by: Smith, Molly
Published: (2019)

The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid Malignancy
by: Laura Mosteo, et al.
Published: (2021-03-01)

Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease
by: Wang QY, et al.
Published: (2019-12-01)

Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation
by: VN Ovechkina, et al.
Published: (2017-01-01)

Transformation of a myelodysplastic syndrome to acute myeloid leukemia and concurrent necrotizing sweet syndrome
by: Olga Vera-Lastra, et al.
Published: (2021-03-01)

Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
by: Alexandra Higgins, et al.
Published: (2020-07-01)

Acute Myeloid Leukemia: Aging and Epigenetics
by: Polina Zjablovskaja, et al.
Published: (2019-12-01)

FLAMSA-RIC for Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis
by: Weerapat Owattanapanich, et al.
Published: (2019-09-01)

Modeling Myeloid Malignancies Using Zebrafish
by: Kathryn S. Potts, et al.
Published: (2017-12-01)

Long-Term Outcomes of Treosulfan- vs. Busulfan-Based Conditioning Regimen for Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia Before Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
by: Sheng Zhu, et al.
Published: (2020-12-01)

Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome aged over 50 years: A single‐center retrospective study
by: Jiafu Huang, et al.
Published: (2020-09-01)

Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome
by: Sagar S. Patel, et al.
Published: (2020-09-01)

Prognostic Markers of Myelodysplastic Syndromes
by: Yuliya Andreevna Veryaskina, et al.
Published: (2020-07-01)

IRAK Family Kinases as Therapeutic Targets for Myelodysplastic Syndrome and Acute Myeloid Leukemia
by: Rhyasen, Garrett W.
Published: (2014)

Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome
by: Ritchie EK
Published: (2012-06-01)

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
by: Huai-Hsuan Huang, et al.
Published: (2019-06-01)

Epigenetics in a Spectrum of Myeloid Diseases and Its Exploitation for Therapy
by: Michael Maher, et al.
Published: (2021-04-01)

Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome
by: R.F. Pinheiro, et al.
Published: (2008-07-01)

The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies
by: Brianna M. Craver, et al.
Published: (2018-04-01)

Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study
by: Tsutsumi, Ikuyo
Published: (2020)

Mutant P53 in pre-leukemic hematopoietic stem cells and the pathogenesis of Myelodysplastic Syndrome
by: Chen, Sisi
Published: (2018)

The Evolving Landscape of Myelodysplastic Syndrome Prognostication
by: Jacob Shreve, et al.
Published: (2020-04-01)

Allogeneic hematopoietic stem cell transplantation for primary myelodysplastic syndrome Transplante alogênico de células progenitoras hematopoiéticas para síndrome mielodisplásica primária
by: Carlos R. Medeiros, et al.
Published: (2004-01-01)

Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia
by: Giorgia Simonetti, et al.
Published: (2021-06-01)

RNA m6A Modification Plays a Key Role in Maintaining Stem Cell Function in Normal and Malignant Hematopoiesis
by: Peipei Wang, et al.
Published: (2021-08-01)

Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome
by: Jonathan Pan, et al.
Published: (2020-10-01)

Safety of bronchoscopy in patients with malignant hematologic disorders
by: Hironori Uruga, et al.
Published: (2020-09-01)

Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML
by: Alexander D. Heini, et al.
Published: (2021-06-01)

Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
by: Vincent G. Sorrentino, et al.
Published: (2021-07-01)

A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome
by: Wei Guoqing, et al.
Published: (2011-11-01)

Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
by: Guangjie Zhao, et al.
Published: (2021-09-01)